Rapid measurement of total plasma homocysteine by HPLC

Clinica Chimica Acta

Volumn 331, Issue 1-2, 2003, Pages 19-23

  Frick, Barbara ^a   Schröcksnadel, Katharina ^a   Neurauter, Gabriele ^a,b   Wirleitner, Barbara ^a   Artner Dworzak, Erika ^a   Fuchs, Dietmar ^a,b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Homocysteine; HPLC; Plasma; Reversed phase; Serum

Indexed keywords

AMMONIUM DERIVATIVE; HOMOCYSTEINE; METHANOL; PHOSPHORIC ACID; REAGENT; THIOL DERIVATIVE; TRIS(2 CARBOXYETHYL)PHOSPHINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; ASSAY; BLOOD LEVEL; BLOOD SAMPLING; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DERIVATIZATION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MEASUREMENT; PH; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; TECHNIQUE; TIME;

EID: 0037402930     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00076-7     Document Type: Article

References (14)

1. Eikelboom J.W., Lonn E., Genest J., Hankley G., Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann. Intern. Med. 131:1999;363-375.
2. Selhub J., Jaques P.F., Rosenberg I.C.H.et al. Serum total homocysteine concentrations in the third national health and nutrition examination survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann. Intern. Med. 131:1999;331-339.
3. Venn B.J., Mann J.I., Williams S.M.et al. Assessment of three levels of folic acid on serum folate and plasma homocysteine: a randomised placebo-controlled double-blind dietary intervention trial. Eur. J. Clin. Nutr. 56:2002;748-754.
4. Leblhuber F., Walli J., Artner-Dworzak E.et al. Hyperhomocysteinemia in dementia. J. Neural Transm. 107:2000;1469-1474.
5. Seshadri S., Beiser A., Selhub J.et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346:2002;476-483.
6. Wu L.L., Wu J.T. Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin. Chim. Acta. 322:2002;21-28.
7. Fuchs D., Jaeger M., Widner B., Wirleitner B., Artner-Dworzak E., Leblhuber F. Is hyperhomocysteinaemia due to oxidative depletion of folate rather than to insufficient dietary intake? Clin. Chem. Med. 39:2001;691-694.
8. Widner B., Enzinger C., Laich A., Wirleitner B., Fuchs D. Hyperhomocysteinemia, pteridines and oxidative stress. Curr. Drug Metabol. 3:2002;225-232.
9. Pfeiffer C.M., Huff D.L., Gunter E.W. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin. Chem. 45:1999;290-292.
10. Ubbink J.B., Vermaak W.J.H., Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J. Chromatogr. 565:1991;441-446.
11. Gilfix B.M., Blank D.W., Rosenblatt D.S. Novel reductant for determination of total plasma homocysteine. Clin. Chem. 43:1997;687-688.
12. Krijt J., Vacková M., Kožich V. Measurement of homocysteine and other aminothiols in plasma: advantages of using tris(2-carboxyethyl)phosphine as reductant compared with tri-n-butylphosphine. Clin. Chem. 47:2001;1821-1828.
13. Ueland P.M., Refsum H., Stabler S.P., Malinow M.R., Andersson A., Allen R.H. Total homocysteine in plasma or serum: methods and clinical applications. Clin. Chem. 39:1993;1764-1779.
14. Kuo K., Still R., Cale S., McDowell I. Standardization (external and internal) of HPLC assay for plasma homocysteine. Clin. Chem. 43:1997;1653-1655.